Allogeneic blood stem cell transplantation following non-myeloablative conditioning for the treatment of malignant and non-malignant diseases.

被引：0
|
作者：
Slavin, S [1 ]
Nagler, A [1 ]
Naparstek, E [1 ]
Ackerstein, A [1 ]
Kapelushnik, Y [1 ]
Varadi, G [1 ]
Allayan, H [1 ]
Kirschbaum, M [1 ]
Ben-Yosef, R [1 ]
Samuel, S [1 ]
机构：
[1] Hadassah Univ Hosp, Dept Bone Marrow Transplant, IL-91120 Jerusalem, Israel
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
225
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [31] Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in paediatric non-malignant diseases
    Elbahy, Samar
    Bonney, Denise
    Campbell, Helen
    Khaled, Tasneem
    Deambrosis, David
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2019, 54 : 208 - 209
  • [32] A new non-myeloablative protocol using fludarabine and low-dose TBI in preparation for allogeneic blood stem cell transplantation for high rise patients with malignant and non-malignant disorders.
    Slavin, S
    Nagler, A
    Naparstek, E
    Varadi, G
    Ben-Yosef, R
    Panighari, S
    Samuel, S
    Ackerstein, R
    BLOOD, 1999, 94 (10) : 388B - 388B
  • [33] Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals
    Slavin, S
    Aker, M
    Shapira, MY
    Panigrahi, S
    Gabriel, C
    Or, R
    TRANSFUSION AND APHERESIS SCIENCE, 2002, 27 (02) : 159 - 166
  • [34] Reduced intensity (RI) allogeneic cord blood hematopoietic cell transplantation (allo CBHCT) in pediatric patients with malignant and non-malignant diseases.
    Del Toro, G
    Bradley, MB
    Satwani, P
    Morris, E
    van de Ven, C
    Cheung, YK
    Yamashiro, D
    Garvin, J
    Bhatia, M
    Roman, E
    Schwartz, J
    Militano, O
    Cooney, E
    Wolownik, K
    Hawks, R
    Foley, S
    Cairo, MS
    BLOOD, 2005, 106 (11) : 453B - 453B
  • [35] Non-myeloablative stem-cell transplantation in 18 cases of hematological diseases.
    Wu, DP
    Ma, X
    Sun, AN
    Fu, CC
    Ruan, CG
    BLOOD, 2003, 102 (11) : 470B - 470B
  • [36] Early and late gastrointestinal complications after allogeneic stem cell transplantation following myeloablative and non-myeloablative conditioning.
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    BLOOD, 2002, 100 (11) : 631A - 631A
  • [37] Allogenic haematopoietic stem cell transplantation with non-myeloablative conditioning in lymphoproliferative diseases
    Yañez, L
    Bermudez, A
    Colorado, M
    Arce, O
    Montes, RP
    Conde, E
    Iriondo, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S360 - S361
  • [38] Non myeloablative conditioning in preparation for allogeneic stem cell transplantation: The future treatment of choice of hematologic malignancies and genetic diseases.
    Slavin, S
    Nagler, A
    Naparstek, E
    Kapelushnik, J
    Varadi, G
    Kirschbaum, M
    Hussien, A
    Ackerstein, A
    Or, R
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 204 - 204
  • [39] Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases
    Al-Toma, Abdulbaqi
    Nijeboer, Petula
    Bouma, Gerd
    Visser, Otto
    Mulder, Chris J. J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) : 17368 - 17375
  • [40] Cord Blood Transplantation (CBT) for the treatment of malignant and non-malignant diseases - A review
    Chiu, B
    Akabutu, J
    IAP 2005: Proceedings of the 4th Asia-Pacific International Academy of Pathology Congress, 2005, : 27 - 30
12345